Grants for Schools & Universities
1,200 open opportunities. Open federal grants for colleges, universities, and other educational institutions, each with a plain-English eligibility summary, deadline, and award amount.
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)
Due Aug 25, 2028National Institutes of Health · Amount varies
Open to U.S. universities, research institutions, nonprofits, and certain government/tribal organizations; foreign organizations are not eligible. This NIH R01 supports early-stage investigators pursuing a new research direction, and applications must include no preliminary data. Award size follows standard R01 limits; aimed at researchers early in their independent careers.
ResearchersSchools & universitiesNonprofitsGovernment / tribalMethod to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional)
Due Sep 7, 2028National Institutes of Health · Amount varies
For existing NCI early-stage-investigator MERIT (R37) awardees applying to extend their award, submitted through their U.S. or eligible institution. The extension provides up to seven years of total support across two segments, giving early-career cancer researchers extra time before a renewal. Eligibility is narrow — limited to current ESI MERIT grantees.
ResearchersSchools & universitiesNarrow eligibilityExploratory Grants in Cancer Control (R21 Clinical Trial Optional)
Due Sep 7, 2028National Institutes of Health · Amount varies
Open to U.S. and foreign research institutions, universities, nonprofits, and certain government/tribal organizations. This NIH/NCI R21 funds early-stage, exploratory research on cancer control — prevention behaviors, screening, etiology, and novel methods. Award size follows standard R21 limits.
ResearchersSchools & universitiesNonprofitsGovernment / tribalAvant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)
Due Sep 25, 2028National Institutes of Health · Amount varies
Open to U.S. and foreign research institutions, universities, nonprofits, and certain government/tribal organizations. This NIH DP1 (Avant-Garde/Avenir) funds high-risk, high-reward research on HIV and substance use — basic, clinical, translational, or implementation science. It backs bold, transformative ideas; award size follows the DP1 mechanism.
ResearchersSchools & universitiesNonprofitsGovernment / tribalNIGMS Institutional Biomedical Undergraduate Research Training (BURT) Program (T34)
Due Sep 25, 2028National Institutes of Health · Amount varies
This NIH/NIGMS T34 training grant funds undergraduate-enrolling institutions to build biomedical research training and mentoring programs that prepare students for PhD or MD/PhD careers. Eligibility is restrictive: applicant institutions must enroll undergraduates and have averaged less than $50M per year in NIH Research Project Grant funding over the last three fiscal years. Foreign institutions and foreign components of U.S. organizations are not eligible to apply.
Schools & universitiesNarrow eligibilityCancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
Due Sep 25, 2028National Institutes of Health · Amount varies
This NIH/NCI P30 Cancer Center Support Grant funds NCI-designated Cancer Centers to integrate their cancer research into a coordinated enterprise. Eligibility is highly restrictive: applicant institutions must already have a large cancer-focused NIH funding base (for example, $6M or $10M in annual direct costs depending on center type). Foreign organizations, foreign components of U.S. organizations, and foreign components are not eligible or allowed.
Schools & universitiesResearchersNarrow eligibilityLimited Competition: Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional)
Due Sep 25, 2028National Institutes of Health · Up to $1.8M
This NIH/NIEHS P42 grant funds Superfund Research Program Centers that combine biomedical and environmental science and engineering to study hazardous substances. By law, eligibility is limited to accredited institutions of higher education, though they may subcontract with other organizations and governments. Awards are large (up to roughly $1.75M), and foreign organizations and foreign components of U.S. organizations are not eligible to apply.
Schools & universitiesResearchersLarge awardNarrow eligibilityAnimal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed)
Due Sep 26, 2028National Institutes of Health · Amount varies
This NIH/ORIP P40 grant funds Animal and Biological Material Resource Centers that maintain specialized animal colonies, cell and tissue cultures, genetic stocks, and related services for the biomedical research community. Proposed centers must have broad relevance across multiple NIH Institutes. Foreign organizations and foreign components of U.S. organizations are not eligible to apply, and foreign components are not allowed.
ResearchersSchools & universitiesNarrow eligibilityResource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed)
Due Sep 28, 2028National Institutes of Health · Amount varies
This NIH/ORIP R24 grant funds research organizations to develop, characterize, or improve models of human health and disease (including new approach methodologies) that are broadly useful across two or more NIH Institutes. Projects narrowly tied to a single disease or to one Institute's interests will not be accepted. Foreign organizations, foreign components of U.S. organizations, and foreign components are not eligible or allowed.
ResearchersSchools & universitiesNarrow eligibilityBRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed)
Due Oct 6, 2028National Institutes of Health · Amount varies
This NIH BRAIN Initiative U24 grant funds organizations to disseminate and integrate existing neuroscience research resources (tools, reagents, training, and access to platforms) into the broader research community. Foreign organizations and foreign components of U.S. organizations are not eligible to apply, and applications involving funded foreign subawards/subcontracts will be rejected. Applicants are typically established research institutions with an existing resource to share.
ResearchersSchools & universitiesNarrow eligibilityUsing Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 CT Not Allowed)
Due Oct 20, 2028National Institutes of Health · Up to $200K
This NIH R21 grant funds secondary analyses that use archived HIV/AIDS data sets and specimen collections to answer questions about maternal, pediatric, and adolescent HIV/AIDS. Both U.S. and foreign organizations are eligible to apply, but foreign components within a project are not allowed. The award ceiling is up to about $200,000.
ResearchersSchools & universitiesBroad eligibilityOccupational Safety and Health Education and Research Centers (T42)
Due Oct 26, 2028Centers for Disease Control and Prevention - ERA · $4.5M–$9M
This CDC/NIOSH program funds academic institutions to run Education and Research Centers providing interdisciplinary training and research in occupational safety and health. Awards are large (roughly $4.5M to $9M). Eligibility is narrow: only one application per institution is allowed, and current holders of a NIOSH T03 training grant cannot receive an award or sub-award under this opportunity.
Schools & universitiesResearchersLarge awardNarrow eligibilityOccupational Safety and Health Training Project Grants (T03)
Due Oct 26, 2028Centers for Disease Control and Prevention - ERA · $50K–$550K
This CDC/NIOSH T03 program funds Training Project Grants for occupational safety and health education, mostly at academic institutions providing undergraduate, graduate, and post-graduate training, plus a limited number of non-academic awards for specialized audiences. Awards range from roughly $50,000 up to about $550,000. Foreign organizations are not eligible to apply.
Schools & universitiesResearchersLarge awardData Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
Due Nov 2, 2028National Institutes of Health · Amount varies
This NIH/NHLBI U24 cooperative agreement funds a Data Coordinating Center to provide data management, biostatistics, and project coordination for investigator-initiated multi-site clinical trials. A companion Clinical Coordinating Center application must be submitted on the same due date for consideration. Both U.S. and foreign organizations may apply, but applications with funded foreign subawards/subcontracts will be rejected.
ResearchersSchools & universitiesBroad eligibilitySingle-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
Due Nov 2, 2028National Institutes of Health · Amount varies
This NIH/NHLBI R61/R33 cooperative agreement funds investigator-initiated single-site clinical trials relevant to the NHLBI mission, using a milestone-driven, two-phase structure. Both U.S. and foreign organizations may apply, but applications including funded foreign subawards/subcontracts will be deemed noncompliant. Applicants are encouraged to include expertise in biostatistics and clinical trial design.
ResearchersSchools & universitiesBroad eligibilityClinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
Due Nov 2, 2028National Institutes of Health · Amount varies
This NIH/NHLBI UG3/UH3 cooperative agreement funds a Clinical Coordinating Center to lead and operate investigator-initiated multi-site clinical trials relevant to the NHLBI mission. A companion Data Coordinating Center application must be submitted on the same due date. Both U.S. and foreign organizations may apply, but applications with funded foreign subawards/subcontracts will be rejected.
ResearchersSchools & universitiesBroad eligibilityEarly Immune System Development and Ontogeny (R01 Clinical Trial Optional)
Due Nov 5, 2028National Institutes of Health · Up to $400K
This NIH R01 grant funds research into early immune system development from the prenatal period through early childhood, including effects of in-utero HIV or antiretroviral exposure. A broad range of applicants is eligible, including colleges and universities, tribal governments, faith- and community-based organizations, minority-serving institutions, and foreign organizations. The award ceiling is up to about $400,000.
ResearchersSchools & universitiesNonprofitsGovernment / tribal+1 moreCCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)
Due Nov 5, 2028National Institutes of Health · Up to $300K
This NIH R01 grant funds basic research into how toxic chemicals of concern injure the skin, supporting the development of medical countermeasures for chemical disasters and emergencies. The award ceiling is up to about $300,000. Foreign organizations and foreign components of U.S. organizations are not eligible to apply, though foreign components within a project may be allowed.
ResearchersSchools & universitiesNarrow eligibilityLimited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
Due Nov 7, 2028National Institutes of Health · Up to $85K
This NIH/NHLBI R03 small grant is a limited competition open only to current or recently completed NHLBI K01, K08, K23, and K25 career-development awardees, to help them transition toward independent research. Projects must be completable in two years, and applicants must maintain at least 40% protected research effort. The award ceiling is up to about $85,000, and foreign organizations are not eligible to apply.
ResearchersSchools & universitiesNarrow eligibilitySmall awardCommunity-Based Participatory Research to Advance Data and Practice Transformation (ADAPT) for Optimizing Oral Health for All (UG3/UH3 Clinical Trial Optional)
Due Nov 16, 2028National Institutes of Health · Up to $300K
This NIH UG3/UH3 cooperative agreement funds community-based participatory research that tests population-level interventions to improve oral health by addressing social and chronic-disease risk factors through cross-sector community partnerships. The award ceiling is up to about $300,000. Foreign organizations and foreign components of U.S. organizations are not eligible to apply, and foreign components are not allowed.
ResearchersSchools & universitiesNonprofitsNarrow eligibility